128 related articles for article (PubMed ID: 9250931)
1. p53 gene mutations and HPV infection in primary head and neck squamous cell carcinomas do not correlate with overall survival: a long-term follow-up study.
Riethdorf S; Friedrich RE; Ostwald C; Barten M; Gogacz P; Gundlach KK; Schlechte H; Becker J; Bregenzer T; Riethdorf L; Löning T
J Oral Pathol Med; 1997 Aug; 26(7):315-21. PubMed ID: 9250931
[TBL] [Abstract][Full Text] [Related]
2. [p53 mutations and HPV infections in squamous epithelial carcinomas of the head-neck region. Long-term follow-up].
Riethdorf S; Friedrich RE; Sühwold J; Ostwald C; Barten M; Gogacz P; Gundlach KK; Schlechte H; Becker J; Bregenzer T; Riethdorf L; Löning T
Mund Kiefer Gesichtschir; 1998 Jan; 2(1):30-4. PubMed ID: 9522570
[TBL] [Abstract][Full Text] [Related]
3. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival.
Haraf DJ; Nodzenski E; Brachman D; Mick R; Montag A; Graves D; Vokes EE; Weichselbaum RR
Clin Cancer Res; 1996 Apr; 2(4):755-62. PubMed ID: 9816227
[TBL] [Abstract][Full Text] [Related]
4. p53 mutations in relation to human papillomavirus type 16 infection in squamous cell carcinomas of the head and neck.
Scholes AG; Liloglou T; Snijders PJ; Hart CA; Jones AS; Woolgar JA; Vaughan ED; Walboomers JM; Field JK
Int J Cancer; 1997 May; 71(5):796-9. PubMed ID: 9180148
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma.
Sisk EA; Soltys SG; Zhu S; Fisher SG; Carey TE; Bradford CR
Head Neck; 2002 Sep; 24(9):841-9. PubMed ID: 12211048
[TBL] [Abstract][Full Text] [Related]
6. A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8.
Hafkamp HC; Speel EJ; Haesevoets A; Bot FJ; Dinjens WN; Ramaekers FC; Hopman AH; Manni JJ
Int J Cancer; 2003 Nov; 107(3):394-400. PubMed ID: 14506739
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the p53 gene and human papillomavirus infection as significant prognostic factors in squamous cell carcinomas of the oral cavity.
Chiba I; Shindoh M; Yasuda M; Yamazaki Y; Amemiya A; Sato Y; Fujinaga K; Notani K; Fukuda H
Oncogene; 1996 Apr; 12(8):1663-8. PubMed ID: 8622886
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus expression and p53 gene mutations in squamous cell carcinoma.
Portugal LG; Goldenberg JD; Wenig BL; Ferrer KT; Nodzenski E; Sabnani JB; Javier C; Weichselbaum RR; Vokes EE
Arch Otolaryngol Head Neck Surg; 1997 Nov; 123(11):1230-4. PubMed ID: 9366703
[TBL] [Abstract][Full Text] [Related]
9. p53 mutations and human papillomavirus infection in oral squamous cell carcinomas: correlation with overall survival.
Kozomara R; Jović N; Magić Z; Branković-Magić M; Minić V
J Craniomaxillofac Surg; 2005 Oct; 33(5):342-8. PubMed ID: 16129609
[TBL] [Abstract][Full Text] [Related]
10. p53, retinoblastoma, and human papillomavirus in squamous cell carcinoma and adjacent normal mucosa of the upper aerodigestive tract.
Lee NK; Ye YW; Chen J; Li X; Waber PG; Nisen PD
Arch Otolaryngol Head Neck Surg; 1993 Oct; 119(10):1125-31. PubMed ID: 8398064
[TBL] [Abstract][Full Text] [Related]
11. p53 alterations and HPV infections are common in oral SCC: p53 gene mutations correlate with the absence of HPV 16-E6 DNA.
Penhallow J; Steingrimsdottir H; Elamin F; Warnakulasuriya S; Farzaneh F; Johnson N; Tavassoli M
Int J Oncol; 1998 Jan; 12(1):59-68. PubMed ID: 9454887
[TBL] [Abstract][Full Text] [Related]
12. Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
Sirianni N; Ha PK; Oelke M; Califano J; Gooding W; Westra W; Whiteside TL; Koch WM; Schneck JP; DeLeo A; Ferris RL
Clin Cancer Res; 2004 Oct; 10(20):6929-37. PubMed ID: 15501971
[TBL] [Abstract][Full Text] [Related]
13. Infection of human papillomavirus (HPV) and Epstein-Barr virus (EBV) and p53 expression in human esophageal carcinoma.
Khurshid A; Kazuya N; Hanae I; Manabu I
J Pak Med Assoc; 1998 May; 48(5):138-42. PubMed ID: 9813975
[TBL] [Abstract][Full Text] [Related]
14. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
15. p53 alteration and human papilloma virus infection in paranasal sinus cancer.
Caruana SM; Zwiebel N; Cocker R; McCormick SA; Eberle RC; Lazarus P
Cancer; 1997 Apr; 79(7):1320-8. PubMed ID: 9083153
[TBL] [Abstract][Full Text] [Related]
16. p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy.
Ganly I; Soutar DS; Brown R; Kaye SB
Br J Cancer; 2000 Jan; 82(2):392-8. PubMed ID: 10646894
[TBL] [Abstract][Full Text] [Related]
17. Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population.
Mitra S; Banerjee S; Misra C; Singh RK; Roy A; Sengupta A; Panda CK; Roychoudhury S
J Clin Pathol; 2007 Sep; 60(9):1040-7. PubMed ID: 17079356
[TBL] [Abstract][Full Text] [Related]
18. p53 mutations and clonality in vulvar carcinomas and squamous hyperplasias: evidence suggesting that squamous hyperplasias do not serve as direct precursors of human papillomavirus-negative vulvar carcinomas.
Kim YT; Thomas NF; Kessis TD; Wilkinson EJ; Hedrick L; Cho KR
Hum Pathol; 1996 Apr; 27(4):389-95. PubMed ID: 8617483
[TBL] [Abstract][Full Text] [Related]
19. Abnormal expression or mutation of TP53 and HPV in vulvar cancer.
Ngan HY; Cheung AN; Liu SS; Yip PS; Tsao SW
Eur J Cancer; 1999 Mar; 35(3):481-4. PubMed ID: 10448303
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.
Gillison ML; Koch WM; Capone RB; Spafford M; Westra WH; Wu L; Zahurak ML; Daniel RW; Viglione M; Symer DE; Shah KV; Sidransky D
J Natl Cancer Inst; 2000 May; 92(9):709-20. PubMed ID: 10793107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
